Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions

O6-methylguanine-methyltransferase (MGMT) promoter methylation status has prognostic and, in the subpopulation of elderly patients, predictive value in newly diagnosed glioblastoma. Therefore, knowledge of the MGMT promoter methylation status is important for clinical decision-making. So far, MGMT t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bienkowski, Michal, Berghoff, Anna S., Marosi, Christine, Wöhrer, Adelheid, Heinzl, Harald, Hainfellner, Johannes A., Preusser, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542181/
https://www.ncbi.nlm.nih.gov/pubmed/26295302
http://dx.doi.org/10.5414/NP300904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542181/
https://www.ncbi.nlm.nih.gov/pubmed/26295302
http://dx.doi.org/10.5414/NP300904

Ejemplares similares